InvestorsHub Logo
Followers 49
Posts 4107
Boards Moderated 0
Alias Born 02/15/2009

Re: None

Monday, 01/14/2019 10:04:13 AM

Monday, January 14, 2019 10:04:13 AM

Post# of 1112
INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell™ System

$5.0 million up front plus $3.0 million in additional milestone payments
? Receive payment for the supply of each INVOcell device.
? Defined minimum revenue targets over the next seven (7) years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INVO News